Mai Kosaka

Application of unbound liver-to-plasma concentration ratio to quantitative projection of cytochrome P450-mediated drug–drug interactions using physiologically based pharmacokinetic modelling approach

Andy Z. X. Zhu, S. Iwasaki, Noriyasu Sano, 2019, Xenobiotica; the fate of foreign compounds in biological systems.

Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1H)-one Derivatives as Orally eIF4A3-Selective Inhibitors.

K. Fukuda, Y. Imaeda, Y. Kosugi, 2017, ACS medicinal chemistry letters.

Risk Assessment Using Cytochrome P450 Time-Dependent Inhibition Assays at Single Time and Concentration in the Early Stage of Drug Discovery.

Y. Kosugi, H. Hirabayashi, Mai Kosaka, 2017, Journal of pharmaceutical sciences.